NextCure  Inc (NXTC) — Capital Reinvestment Ratio

Latest as of December 2018: 0.08x

NextCure  Inc (NXTC) has a Capital Reinvestment Ratio of 0.08x as of December 2018, meaning it reinvests 0% of its operating cash flow ($22.47 Million) in capital expenditures ($1.90 Million). See NextCure  Inc balance sheet independence to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.08x
Capex / Operating Cash Flow

Operating Cash Flow

$22.47 Million
USD

Capital Expenditures

$1.90 Million
USD

Data as of

Dec 2018
Most recent filing

NextCure  Inc Capital Reinvestment Ratio (2018–2018)

This chart tracks NextCure  Inc's Capital Reinvestment Ratio across 1 annual periods. Check NextCure  Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for NextCure  Inc (2018–2018)

Year-by-year Capital Reinvestment Ratio for NextCure  Inc from 2018 to 2018. For live market cap and broader valuation context, see NextCure  Inc (NXTC) market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2018 0.38x $7.99 Million $3.06 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow